(Updated - December 5, 2022 4:05 PM EST)

Credit Suisse analyst Richard Law downgraded Kymera Therapeutics (NASDAQ: KYMR) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE